» Articles » PMID: 38846528

3D Printing of Interferon γ-preconditioned NSC-derived Exosomes/collagen/chitosan Biological Scaffolds for Neurological Recovery After TBI

Overview
Journal Bioact Mater
Date 2024 Jun 7
PMID 38846528
Authors
Affiliations
Soon will be listed here.
Abstract

The reconstruction of neural function and recovery of chronic damage following traumatic brain injury (TBI) remain significant clinical challenges. Exosomes derived from neural stem cells (NSCs) offer various benefits in TBI treatment. Numerous studies confirmed that appropriate preconditioning methods enhanced the targeted efficacy of exosome therapy. Interferon-gamma (IFN-γ) possesses immunomodulatory capabilities and is widely involved in neurological disorders. In this study, IFN-γ was employed for preconditioning NSCs to enhance the efficacy of exosome (IFN-Exo, IE) for TBI. miRNA sequencing revealed the potential of IFN-Exo in promoting neural differentiation and modulating inflammatory responses. Through low-temperature 3D printing, IFN-Exo was combined with collagen/chitosan (3D-CC-IE) to preserve the biological activity of the exosome. The delivery of exosomes via biomaterial scaffolds benefited the retention and therapeutic potential of exosomes, ensuring that they could exert long-term effects at the injury site. The 3D-CC-IE scaffold exhibited excellent biocompatibility and mechanical properties. Subsequently, 3D-CC-IE scaffold significantly improved impaired motor and cognitive functions after TBI in rat. Histological results showed that 3D-CC-IE scaffold markedly facilitated the reconstruction of damaged neural tissue and promoted endogenous neurogenesis. Further mechanistic validation suggested that IFN-Exo alleviated neuroinflammation by modulating the MAPK/mTOR signaling pathway. In summary, the results of this study indicated that 3D-CC-IE scaffold engaged in long-term pathophysiological processes, fostering neural function recovery after TBI, offering a promising regenerative therapy avenue.

Citing Articles

Biomaterials for neuroengineering: applications and challenges.

Wu H, Feng E, Yin H, Zhang Y, Chen G, Zhu B Regen Biomater. 2025; 12:rbae137.

PMID: 40007617 PMC: 11855295. DOI: 10.1093/rb/rbae137.


MSCs-EVs harboring OA immune memory reprogram macrophage phenotype via modulation of the mt-ND3/NADH-CoQ axis for OA treatment.

Zhan J, Zou J, Pang Q, Chen Z, Liu J, Liu S J Nanobiotechnology. 2025; 23(1):140.

PMID: 40001168 PMC: 11863759. DOI: 10.1186/s12951-025-03216-1.


Three-Dimensional Printing/Bioprinting and Cellular Therapies for Regenerative Medicine: Current Advances.

Sousa A, Alvites R, Lopes B, Sousa P, Moreira A, Coelho A J Funct Biomater. 2025; 16(1).

PMID: 39852584 PMC: 11765675. DOI: 10.3390/jfb16010028.


Exosomes in Central Nervous System Diseases: A Comprehensive Review of Emerging Research and Clinical Frontiers.

Li J, Song J, Jia L, Wang M, Ji X, Meng R Biomolecules. 2025; 14(12.

PMID: 39766226 PMC: 11673277. DOI: 10.3390/biom14121519.


Advances in 3D printing for the repair of tympanic membrane perforation: a comprehensive review.

Xue H, Chen S, Hu Y, Huang J, Shen Y Front Bioeng Biotechnol. 2024; 12:1439499.

PMID: 39188376 PMC: 11345550. DOI: 10.3389/fbioe.2024.1439499.

References
1.
Jiao S, Liu Y, Yao Y, Teng J . miR-124 promotes proliferation and neural differentiation of neural stem cells through targeting DACT1 and activating Wnt/β-catenin pathways. Mol Cell Biochem. 2018; 449(1-2):305-314. DOI: 10.1007/s11010-018-3367-z. View

2.
Rong Y, Liu W, Wang J, Fan J, Luo Y, Li L . Neural stem cell-derived small extracellular vesicles attenuate apoptosis and neuroinflammation after traumatic spinal cord injury by activating autophagy. Cell Death Dis. 2019; 10(5):340. PMC: 6472377. DOI: 10.1038/s41419-019-1571-8. View

3.
Cossetti C, Iraci N, Mercer T, Leonardi T, Alpi E, Drago D . Extracellular vesicles from neural stem cells transfer IFN-γ via Ifngr1 to activate Stat1 signaling in target cells. Mol Cell. 2014; 56(2):193-204. PMC: 4578249. DOI: 10.1016/j.molcel.2014.08.020. View

4.
Qian F, Han Y, Han Z, Zhang D, Zhang L, Zhao G . In Situ implantable, post-trauma microenvironment-responsive, ROS Depletion Hydrogels for the treatment of Traumatic brain injury. Biomaterials. 2021; 270:120675. DOI: 10.1016/j.biomaterials.2021.120675. View

5.
Yan F, Li M, Zhang H, Li G, Hua Y, Shen Y . Collagen-chitosan scaffold impregnated with bone marrow mesenchymal stem cells for treatment of traumatic brain injury. Neural Regen Res. 2019; 14(10):1780-1786. PMC: 6585548. DOI: 10.4103/1673-5374.257533. View